PROTAGONIST THERAPEUTICS Trademark

Trademark Overview


On Monday, December 18, 2023, a trademark application was filed for PROTAGONIST THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the PROTAGONIST THERAPEUTICS trademark a serial number of 98319352. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, December 18, 2023. This trademark is owned by Protagonist Therapeutics, Inc.. The PROTAGONIST THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment of oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders

Providing online information to patients and healthcare providers relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders

Scientific and medical research relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders
protagonist therapeutics

General Information


Serial Number98319352
Word MarkPROTAGONIST THERAPEUTICS
Filing DateMonday, December 18, 2023
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, December 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the word "Protagonist" above the word "Therapeutics" to the right of the words is a DNA double helix.
Goods and ServicesPharmaceutical preparations for the treatment of oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesProviding online information to patients and healthcare providers relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders
Goods and ServicesScientific and medical research relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 18, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 18, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 18, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameProtagonist Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Trademark Events


Event DateEvent Description
Monday, December 18, 2023NEW APPLICATION ENTERED
Tuesday, March 26, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, March 26, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED